Gainers
- Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
- Aditxt, Inc. (NASDAQ: ADTX) jumped 113.8% to close at $0.37.
- Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) surged 101% to close at $3.86 after a late Monday Form 4 filing showed multiple insider purchases of the stock.
- NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) climbed 79.3% to close at $29.90 on Tuesday as the stock started trading on a 1-for-30 reverse split basis.
- 89bio, Inc. (NASDAQ: ETNB) shares rose 40% to close at $7.00. Analysts reportedly said Akero's NASH data could be a positive for the company's Pegoza program in NASH.
- Motorsport Games Inc. (NASDAQ: MSGM) climbed 28.1% to close at $0.97. Motorsport Games, last month, reported worse-than-expected Q2 EPS results.
- Akouos, Inc. (NASDAQ: AKUS) gained 28% to close at $4.48. The FDA has signed off Akouos Investigational New Drug application to initiate a Phase 1/2 trial of AK-OTOF, gene therapy for otoferlin gene (OTOF)-mediated hearing loss.
- Infobird Co., Ltd (NASDAQ: IFBD) jumped 28% to settle at $2.47.
- Golden Path Acquisition Corporation (NASDAQ: GPCO) rose 22.4% to settle at $8.69.
- Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 22.3% to close at $0.4131.
- Immuneering Corporation (NASDAQ: IMRX) jumped 22.1% to close at $12.00. Immuneering recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its product candidate IMM-1-104 in development for the treatment of advanced RAS mutant solid tumors.
- Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) rose 21% to close at $0.2299.
- VNET Group, Inc. (NASDAQ: VNET) gained 20.7% to close at $5.66 after the company announced the receipt of a preliminary non-binding proposal to acquire all of its shares and formation of a special committee to review the proposal.
- Cosmos Holdings Inc. (NASDAQ: COSM) climbed 19.7% to settle at $0.4216. Cosmos Health’s subsidiary SkyPharm recently launched its first Sky Premium Life products on Amazon in the U.S.
- Palisade Bio, Inc. (NASDAQ: PALI) jumped 18.3% to settle at $0.1782. Palisade Bio was Granted U.S. patent titled 'Administration of serine protease inhibitors to the stomach.'
- Aprea Therapeutics, Inc. (NASDAQ: APRE) gained 17.7% to close at $0.9299.
- Phunware, Inc. (NASDAQ: PHUN) surged 15.6% to settle at $1.63.
- NLS Pharmaceutics AG (NASDAQ: NLSP) gained 14.2% to close at $1.12. Laidlaw & Co. recently initiated coverage on NLS Pharmaceutics with a Buy rating and announced a price target of $6.
- iBio, Inc. (NYSE: IBIO) rose 13.7% to close at $0.3080 after declining over 4% on Monday.
- Planet Labs PBC (NYSE: PL) gained 13.5% to close at $6.15 after the company reported better-than-expected Q2 results and raised guidance.
- Aehr Test Systems (NASDAQ: AEHR) gained 13.5% to close at $15.99 after the company received a wafer level burn-in system order.
- HilleVax, Inc. (NASDAQ: HLVX) rose 12.4% to close at $22.01.
- Hycroft Mining Holding Corporation (NASDAQ: HYMC) rose 12.1% to close at $0.8914. The company earlier reported initial drill results from its 2022-2023 exploration program.
- Entrada Therapeutics, Inc. (NASDAQ: TRDA) surged 10.3% to settle at $13.14.
- Tyme Technologies, Inc. (NASDAQ: TYME) gained 9.1% to close at $0.2807 after gaining around 4% on Monday.
- V2X, Inc. (NYSE: VVX) gained 8.6% to close at $41.25.
- LSB Industries, Inc. (NYSE: LXU) gained 6.3% to close at $17.04. Piper Sandler initiated coverage on LSB Industries with an Overweight rating and announced a price target of $26.
- Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) shares rose 4.9% to close at $0.7659 after the FDA granted Syros Pharmaceuticals Orphan Drug Designation for the treatment of pancreatic cancer.
- Core & Main, Inc. (NYSE: CNM) rose 2.5% to close at $25.11 following upbeat Q2 results.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
- Cardiff Oncology, Inc. (NASDAQ: CRDF) shares dipped 41.1% to close at $1.89 on Tuesday. Following a strategic review, Cardiff Oncology decided it will not independently fund any future clinical activities in metastatic castrate-resistant prostate cancer (mCRPC), citing clinical data and therapeutic landscape.
- Rent the Runway, Inc. (NASDAQ: RENT) shares dropped 38.7% to close at $3.02 after the company reported issued Q3 guidance below estimates and announced a workforce reduction of 24% of corporate employees. Credit Suisse (SIX:CSGN) downgraded the stock from Outperform to Neutral and lowered the price target from $7 to $4.
- InMed Pharmaceuticals Inc. (NASDAQ: INM) fell 35.7% to close at $12.07. InMed Pharmaceuticals recently announced a $6 million private placement priced at $8.68 per share.
- Codiak BioSciences, Inc. (NASDAQ: CDAK) dipped 33.5% to close at $1.11 after the company priced 13.33 million share offering plus accompanying warrants at combined price of $1.50 per share plus warrant.
- Benitec Biopharma Inc. (NASDAQ: BNTC) declined 28.3% to close at $0.4550 as the company reported pricing of $18 million underwritten public offering.
- Edgewise Therapeutics, Inc. (NASDAQ: EWTX) dropped 24% to settle at $10.32. Edgewise Therapeutics announced a proposed $100 million offering of common stock.
- Nocera, Inc. (NASDAQ: NCRA) fell 22.5% to close at $1.96.
- Venus Concept Inc. (NASDAQ: VERO) dropped 21.5% to close at $0.5508.
- AMTD Digital Inc. (NYSE: HKD) declined 21.1% to close at $46.00.
- Braze, Inc. (NASDAQ: BRZE) fell 19.3% to close at $35.18 after the company reported Q2 earnings results and issued Q3 2023 adjusted EPS guidance below estimates.
- PolyPid Ltd. (NASDAQ: PYPD) fell 18.7% to settle at $1.39 after jumping 58% on Monday. The company earlier announced it will present Phase 2 D-PLEX₁₀₀ data at the European Society for Coloproctology Scientific Conference next week.
- Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) dropped 17.8% to close at $7.11.
- Relay Therapeutics, Inc. (NASDAQ: RLAY) shares fell 16.6% to close at $24.03. Relay Therapeutics priced 11.32 million share public offering of common stock at $26.50 per share.
- Soluna Holdings, Inc. (NASDAQ: SLNH) fell 15.6% to close at $2.66.
- Hut 8 Mining Corp. (NASDAQ: HUT) dipped 15.4% to settle at $2.03.
- Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) dropped 15.2% to close at $26.45.
- Jasper Therapeutics, Inc. (NASDAQ: JSPR) fell 15.1% to settle at $1.58.
- Boxed, Inc. (NYSE: BOXD) declined 14.8% to settle at $0.9283.
- Kingsoft Cloud Holdings Limited (NASDAQ: KC) fell 14.4% to close at $2.26.
- Innovid Corp. (NYSE: CTV) fell 14.2% to close at $3.08. Morgan Stanley (NYSE:MS) initiated coverage on Innovid with an Underweight rating and announced a price target of $2.7.
- The RealReal, Inc. (NASDAQ: REAL) declined 14.1% to close at $2.26.
- Magic Empire Global Limited (NASDAQ: MEGL) dropped 14% to close at $5.16.
- Syneos Health, Inc. (NASDAQ: SYNH) fell 13.7% to settle at $54.72.
- LumiraDx Limited (NASDAQ: LMDX) declined 13.6% to settle at $1.33.
- Rubius Therapeutics, Inc. (NASDAQ: RUBY) fell 13.4% to close at $0.9270 after the company discontinued ongoing Phase 1 trials of RTX-240 and RTX-224 in advanced solid tumors.
- The Children's Place, Inc. (NASDAQ: PLCE) declined 13.4% to settle at $35.17.
- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) slipped 13.4% to close at $13.91.
- Unity Software Inc. (NYSE: U) dropped 13.4% to close at $36.66 after Applovin announced it does not intend to submit another proposal to combine with the company and has withdrawn its Aug. 9 proposal.
- Carvana Co. (NYSE: CVNA) fell 12.9% to close at $36.81.
- MicroStrategy Incorporated (NASDAQ: MSTR) dropped 12.1% to close at $231.25 after August CPI data showed greater-than-expected US inflation.
- WalkMe Ltd. (NASDAQ: WKME) declined 11.9% to close at $9.74. WalkMe announced the departure of Chief Financial Officer Andrew Casey.
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) dipped 11.7% to close at $6.14.
- Asana, Inc. (NYSE: ASAN) fell 11.5% to close at $25.42.
- Wayfair Inc. (NYSE: W) fell 11.1% to close at $49.76.
- Upstart (NASDAQ:UPST) Holdings, Inc. (NASDAQ: UPST) fell 10.9% to close at $24.97.
- Peloton (NASDAQ:PTON) Interactive, Inc. (NASDAQ: PTON) fell 10.3% to close at $9.91 after the company announced Executive Chair John Foley will step down, effective Sept. 12. Karen Boone has been elected Chairperson of the Board.
- BridgeBio Pharma, Inc. (NASDAQ: BBIO) fell 10.1% to close at $11.11.
- Crocs, Inc. (NASDAQ: CROX) dropped 9.8% to settle at $75.39 amid overall market weakness as August CPI readings showed inflation came in greater than expected.
- NVIDIA Corporation (NASDAQ: NASDAQ:NVDA) tumbled 9.5% to close at $131.31. Shares of semiconductor stocks at large traded lower after August CPI data showed greater-than-expected US inflation, which has caused economic concerns and raised expectations for aggressive Fed policy. Fed rate hikes could drive a slowdown in the economy, which could pressure demand in semiconductor and chip end markets.
- Tuesday Morning Corporation (NASDAQ: TUEM) fell 8.8% to close at $0.1766. The company recently announced it has entered into an agreement to secure $32 million in convertible debt financing.
- Coinbase (NASDAQ:COIN) Global, Inc. (NASDAQ: COIN) declined 8.8% to settle at $75.25 as cryptocurrencies fell following worse-than-expected US inflation data.
- Amazon.com, Inc. (NASDAQ: NASDAQ:AMZN) dipped 7.1% to close at $126.82 after August CPI data showed greater-than-expected US inflation.
- AppLovin Corporation (NASDAQ: APP) fell 6.4% to close at $26.68. Applovin announced it does not intend to submit another proposal to combine with Unity Software and has withdrawn its Aug. 9 proposal.
- Apple Inc. (NASDAQ: NASDAQ:AAPL) fell 5.9% to close at $153.84 amid overall market weakness after August CPI readings showed inflation came in greater than expected.
- Microsoft Corporation (NASDAQ: NASDAQ:MSFT) fell 5.5% to settle at $251.99 after August CPI data showed greater-than-expected US inflation.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.